(Dis)similar analogues of riboswitch metabolites as antibacterial lead compounds

Journal of Medicinal Chemistry

Volumn 58, Issue 8, 2015, Pages 3275-3286

  Matzner, Daniel ^a   Mayer, Günter ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS AFFECTING METABOLISM; ANTIBIOTIC AGENT; ARTIFICIAL RIBOSWITCH ACTIVATOR; LIGAND; RNA; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL RNA; RIBOSWITCH;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG ACTIVITY; DRUG ANALYSIS; DRUG DESIGN; DRUG SYNTHESIS; DRUG TARGETING; FRAGMENT BASED SCREENING; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; HUMAN; LIGAND BINDING; MULTIDRUG RESISTANCE; NONHUMAN; RIBOSWITCH; ANIMAL; ANTAGONISTS AND INHIBITORS; BACTERIAL INFECTIONS; BACTERIUM; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; GENETICS; METABOLISM; MICROBIOLOGY; MOLECULARLY TARGETED THERAPY; PROCEDURES;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG DISCOVERY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MODELS, MOLECULAR; MOLECULAR TARGETED THERAPY; RIBOSWITCH; RNA, BACTERIAL;

EID: 84928473814     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm500868e     Document Type: Article

References (103)

1. Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States, 2013. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf (accessed Dec 18, 2014).
2. Roberts, R. R.; Hota, B.; Ahmad, I.; Scott, R. D., 2nd; Foster, S. D.; Abbasi, F.; Schabowski, S.; Kampe, L. M.; Ciavarella, G. G.; Supino, M.; Naples, J.; Cordell, R.; Levy, S. B.; Weinstein, R. A. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship Clin. Infect. Dis. 2009, 49, 1175-1184
3. European Centre for Disease Prevention and Control. ECDC/EMEA Joint technical report. The bacterial challenge: time to react, 2009. http://www.ecdc.europa.eu/en/publications/Publications/0909-TER-The-Bacterial-Challenge-Time-to-React.pdf (accessed Dec 18, 2014).
4. European Centre for Disease Prevention and Control. Annual epidemiological report, 2013. http://www.ecdc.europa.eu/en/publications/Publications/annual-epidemiological-report-2013.pdf (accessed Dec 18, 2014).
5. World Health Organization. The evolving threat of antimicrobial resistance: options for action, 2012. http://whqlibdoc.who.int/publications/2012/9789241503181-eng.pdf (accessed Dec 18, 2014).
6. Blount, K. F.; Breaker, R. R. Riboswitches as antibacterial drug targets Nat. Biotechnol. 2006, 24, 1558-1564
7. Deigan, K. E.; Ferre-D'Amare, A. R. Riboswitches: discovery of drugs that target bacterial gene-regulatory RNAs Acc. Chem. Res. 2011, 44, 1329-1338
8. Penchovsky, R.; Stoilova, C. C. Riboswitch-based antibacterial drug discovery using high-throughput screening methods Expert Opin. Drug Discovery 2013, 8, 65-82
9. Breaker, R. R. Prospects for riboswitch discovery and analysis Mol. Cell 2011, 43, 867-879
10. Caron, M. P.; Bastet, L.; Lussier, A.; Simoneau-Roy, M.; Masse, E.; Lafontaine, D. A. Dual-acting riboswitch control of translation initiation and mRNA decay Proc. Natl. Acad. Sci. U.S.A. 2012, 109, E3444-E3453
11. Hollands, K.; Proshkin, S.; Sklyarova, S.; Epshtein, V.; Mironov, A.; Nudler, E.; Groisman, E. A. Riboswitch control of Rho-dependent transcription termination Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 5376-5381
12. Loh, E.; Dussurget, O.; Gripenland, J.; Vaitkevicius, K.; Tiensuu, T.; Mandin, P.; Repoila, F.; Buchrieser, C.; Cossart, P.; Johansson, J. A trans-acting riboswitch controls expression of the virulence regulator PrfA in Listeria monocytogenes Cell 2009, 139, 770-779
13. Winkler, W.; Nahvi, A.; Breaker, R. R. Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression Nature 2002, 419, 952-956
14. Grundy, F. J.; Henkin, T. M. The S box regulon: a new global transcription termination control system for methionine and cysteine biosynthesis genes in Gram-positive bacteria Mol. Microbiol. 1998, 30, 737-749
15. Winkler, W. C.; Nahvi, A.; Sudarsan, N.; Barrick, J. E.; Breaker, R. R. An mRNA structure that controls gene expression by binding S -adenosylmethionine Nat. Struct. Biol. 2003, 10, 701-707
16. Corbino, K. A.; Barrick, J. E.; Lim, J.; Welz, R.; Tucker, B. J.; Puskarz, I.; Mandal, M.; Rudnick, N. D.; Breaker, R. R. Evidence for a second class of S -adenosylmethionine riboswitches and other regulatory RNA motifs in alpha-proteobacteria Genome Biol. 2005, 6, R70
17. Lu, C.; Smith, A. M.; Fuchs, R. T.; Ding, F.; Rajashankar, K.; Henkin, T. M.; Ke, A. Crystal structures of the SAM-III/S(MK) riboswitch reveal the SAM-dependent translation inhibition mechanism Nat. Struct. Mol. Biol. 2008, 15, 1076-1083
18. Poiata, E.; Meyer, M. M.; Ames, T. D.; Breaker, R. R. A variant riboswitch aptamer class for S-adenosylmethionine common in marine bacteria RNA 2009, 15, 2046-2056
19. Winkler, W. C.; Cohen-Chalamish, S.; Breaker, R. R. An mRNA structure that controls gene expression by binding FMN Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 15908-15913
20. Sudarsan, N.; Wickiser, J. K.; Nakamura, S.; Ebert, M. S.; Breaker, R. R. An mRNA structure in bacteria that controls gene expression by binding lysine Genes Dev. 2003, 17, 2688-2697
21. Batey, R. T.; Gilbert, S. D.; Montange, R. K. Structure of a natural guanine-responsive riboswitch complexed with the metabolite hypoxanthine Nature 2004, 432, 411-415
22. Mandal, M.; Breaker, R. R. Gene regulation by riboswitches Nat. Rev. Mol. Cell Biol. 2004, 5, 451-463
23. Mandal, M.; Breaker, R. R. Adenine riboswitches and gene activation by disruption of a transcription terminator Nat. Struct. Mol. Biol. 2004, 11, 29-35
24. Lee, E. R.; Baker, J. L.; Weinberg, Z.; Sudarsan, N.; Breaker, R. R. An allosteric self-splicing ribozyme triggered by a bacterial second messenger Science 2010, 329, 845-848
25. Sudarsan, N.; Lee, E. R.; Weinberg, Z.; Moy, R. H.; Kim, J. N.; Link, K. H.; Breaker, R. R. Riboswitches in eubacteria sense the second messenger cyclic di-GMP Science 2008, 321, 411-413
26. Nelson, J. W.; Sudarsan, N.; Furukawa, K.; Weinberg, Z.; Wang, J. X.; Breaker, R. R. Riboswitches in eubacteria sense the second messenger c-di-AMP Nat. Chem. Biol. 2013, 9, 834-839
27. Winkler, W. C.; Nahvi, A.; Roth, A.; Collins, J. A.; Breaker, R. R. Control of gene expression by a natural metabolite-responsive ribozyme Nature 2004, 428, 281-286
28. Weinberg, Z.; Barrick, J. E.; Yao, Z.; Roth, A.; Kim, J. N.; Gore, J.; Wang, J. X.; Lee, E. R.; Block, K. F.; Sudarsan, N.; Neph, S.; Tompa, M.; Ruzzo, W. L.; Breaker, R. R. Identification of 22 candidate structured RNAs in bacteria using the CMfinder comparative genomics pipeline Nucleic Acids Res. 2007, 35, 4809-4819
29. Serganov, A.; Nudler, E. A decade of riboswitches Cell 2013, 152, 17-24
30. Buck, J.; Furtig, B.; Noeske, J.; Wohnert, J.; Schwalbe, H. Time-resolved NMR methods resolving ligand-induced RNA folding at atomic resolution Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 15699-15704
31. Klein, D. J.; Ferre-D'Amare, A. R. Structural basis of glmS ribozyme activation by glucosamine-6-phosphate Science 2006, 313, 1752-1756
32. Cochrane, J. C.; Lipchock, S. V.; Strobel, S. A. Structural investigation of the GlmS ribozyme bound to its catalytic cofactor Chem. Biol. 2007, 14, 97-105
33. Serganov, A.; Yuan, Y. R.; Pikovskaya, O.; Polonskaia, A.; Malinina, L.; Phan, A. T.; Hobartner, C.; Micura, R.; Breaker, R. R.; Patel, D. J. Structural basis for discriminative regulation of gene expression by adenine- and guanine-sensing mRNAs Chem. Biol. 2004, 11, 1729-1741
34. Garst, A. D.; Heroux, A.; Rambo, R. P.; Batey, R. T. Crystal structure of the lysine riboswitch regulatory mRNA element J. Biol. Chem. 2008, 283, 22347-22351
35. Serganov, A.; Huang, L.; Patel, D. J. Structural insights into amino acid binding and gene control by a lysine riboswitch Nature 2008, 455, 1263-1267
36. Serganov, A.; Polonskaia, A.; Phan, A. T.; Breaker, R. R.; Patel, D. J. Structural basis for gene regulation by a thiamine pyrophosphate-sensing riboswitch Nature 2006, 441, 1167-1171
37. Thore, S.; Leibundgut, M.; Ban, N. Structure of the eukaryotic thiamine pyrophosphate riboswitch with its regulatory ligand Science 2006, 312, 1208-1211
38. Serganov, A.; Huang, L. L.; Patel, D. J. Coenzyme recognition and gene regulation by a flavin mononucleotide riboswitch Nature 2009, 458, 233-237
39. Peselis, A.; Serganov, A. Themes and variations in riboswitch structure and function Biochim. Biophys. Acta 2014, 1839, 908-918
40. Lunse, C. E.; Schmidt, M. S.; Wittmann, V.; Mayer, G. Carba-sugars activate the glmS-riboswitch of Staphylococcus aureus ACS Chem. Biol. 2011, 6, 675-678
41. Stoddard, C. D.; Widmann, J.; Trausch, J. J.; Marcano-Velazquez, J. G.; Knight, R.; Batey, R. T. Nucleotides adjacent to the ligand-binding pocket are linked to activity tuning in the purine riboswitch J. Mol. Biol. 2013, 425, 1596-1611
42. Smith, K. D.; Lipchock, S. V.; Ames, T. D.; Wang, J.; Breaker, R. R.; Strobel, S. A. Structural basis of ligand binding by a c-di-GMP riboswitch Nat. Struct. Mol. Biol. 2009, 16, 1218-1223
43. Shanahan, C. A.; Gaffney, B. L.; Jones, R. A.; Strobel, S. A. Differential analogue binding by two classes of c-di-GMP riboswitches J. Am. Chem. Soc. 2011, 133, 15578-15592
44. Garst, A. D.; Batey, R. T. A switch in time: detailing the life of a riboswitch Biochim. Biophys. Acta 2009, 1789, 584-591
45. Porter, E. B.; Marcano-Velazquez, J. G.; Batey, R. T. The purine riboswitch as a model system for exploring RNA biology and chemistry Biochim. Biophys. Acta 2014, 1839, 919-930
46. Mayer, G.; Famulok, M. High-throughput-compatible assay for glmS riboswitch metabolite dependence ChemBioChem 2006, 7, 602-604
47. Blount, K.; Puskarz, I.; Penchovsky, R.; Breaker, R. Development and application of a high-throughput assay for glmS riboswitch activators RNA Biol. 2006, 3, 77-81
48. Cressina, E.; Chen, L. H.; Abell, C.; Leeper, F. J.; Smith, A. G. Fragment screening against the thiamine pyrophosphate riboswitch thiM Chem. Sci. 2011, 2, 157-165
49. Chen, L.; Cressina, E.; Dixon, N.; Erixon, K.; Agyei-Owusu, K.; Micklefield, J.; Smith, A. G.; Abell, C.; Leeper, F. J. Probing riboswitch-ligand interactions using thiamine pyrophosphate analogues Org. Biomol. Chem. 2012, 10, 5924-5931
50. Baird, N. J.; Ferre-D'Amare, A. R. Idiosyncratically tuned switching behavior of riboswitch aptamer domains revealed by comparative small-angle X-ray scattering analysis RNA 2010, 16, 598-609
51. Chen, B.; Zuo, X.; Wang, Y. X.; Dayie, T. K. Multiple conformations of SAM-II riboswitch detected with SAXS and NMR spectroscopy Nucleic Acids Res. 2012, 40, 3117-3130
52. Noeske, J.; Richter, C.; Grundl, M. A.; Nasiri, H. R.; Schwalbe, H.; Wohnert, J. An intermolecular base triple as the basis of ligand specificity and affinity in the guanine- and adenine-sensing riboswitch RNAs Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 1372-1377
53. Furtig, B.; Richter, C.; Wohnert, J.; Schwalbe, H. NMR spectroscopy of RNA ChemBioChem 2003, 4, 936-962
54. Sudarsan, N.; Cohen-Chalamish, S.; Nakamura, S.; Emilsson, G. M.; Breaker, R. R. Thiamine pyrophosphate riboswitches are targets for the antimicrobial compound pyrithiamine Chem. Biol. 2005, 12, 1325-1335
55. Blount, K. F.; Wang, J. X.; Lim, J.; Sudarsan, N.; Breaker, R. R. Antibacterial lysine analogs that target lysine riboswitches Nat. Chem. Biol. 2007, 3, 44-49
56. Mulhbacher, J.; Brouillette, E.; Allard, M.; Fortier, L. C.; Malouin, F.; Lafontaine, D. A. Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways PLoS Pathog. 2010, 6, e1000865
57. Hickey, S. F.; Hammond, M. C. Structure-guided design of fluorescent S -adenosylmethionine analogs for a high-throughput screen to target SAM-I riboswitch RNAs Chem. Biol. 2014, 21, 345-356
58. Furukawa, R.; Gu, H. Z.; Sudarsan, N.; Hayakawa, Y.; Hyodo, M.; Breaker, R. R. Identification of ligand analogues that control c-di-GMP riboswitches ACS Chem. Biol. 2012, 7, 1436-1443
59. Fedor, M. J. Structure and function of the hairpin ribozyme J. Mol. Biol. 2000, 297, 269-291
60. Eckert, H.; Bajorath, J. Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches Drug Discovery Today 2007, 12, 225-233
61. Haller, A.; Souliere, M. F.; Micura, R. The dynamic nature of RNA as key to understanding riboswitch mechanisms Acc. Chem. Res. 2011, 44, 1339-1348
62. Zhang, J.; Lau, M. W.; Ferre-D'Amare, A. R. Ribozymes and riboswitches: modulation of RNA function by small molecules Biochemistry 2010, 49, 9123-9131
63. Chinnappan, R.; Dube, A.; Lemay, J. F.; Lafontaine, D. A. Fluorescence monitoring of riboswitch transcription regulation using a dual molecular beacon assay Nucleic Acids Res. 2013, 41, e106
64. Congreve, M.; Chessari, G.; Tisi, D.; Woodhead, A. J. Recent developments in fragment-based drug discovery J. Med. Chem. 2008, 51, 3661-3680
65. Hann, M. M.; Leach, A. R.; Harper, G. Molecular complexity and its impact on the probability of finding leads for drug discovery J. Chem. Inf. Model. 2001, 41, 856-864
66. Chen, L.; Cressina, E.; Leeper, F. J.; Smith, A. G.; Abell, C. A fragment-based approach to identifying ligands for riboswitches ACS Chem. Biol. 2010, 5, 355-358
67. Ciulli, A.; Abell, C. Biophysical tools to monitor enzyme-ligand interactions of enzymes involved in vitamin biosynthesis Biochem. Soc. Trans. 2005, 33, 767-771
68. Warner, K. D.; Homan, P.; Weeks, K. M.; Smith, A. G.; Abell, C.; Ferre-D'Amare, A. R. Validating fragment-based drug discovery for biological RNAs: lead fragments bind and remodel the TPP riboswitch specifically Chem. Biol. 2014, 21, 591-595
69. Ferre-D'Amare, A. R. The glmS ribozyme: use of a small molecule coenzyme by a gene-regulatory RNA Q. Rev. Biophys. 2010, 43, 423-447
70. Kim, J. N.; Blount, K. F.; Puskarz, I.; Lim, J.; Link, K. H.; Breaker, R. R. Design and antimicrobial action of purine analogues that bind guanine riboswitches ACS Chem. Biol. 2009, 4, 915-927
71. Lim, J.; Grove, B. C.; Roth, A.; Breaker, R. R. Characteristics of ligand recognition by a glmS self-cleaving ribozyme Angew. Chem., Int. Ed. 2006, 45, 6689-6693
72. McCarthy, T. J.; Plog, M. A.; Floy, S. A.; Jansen, J. A.; Soukup, J. K.; Soukup, G. A. Ligand requirements for glmS ribozyme self-cleavage Chem. Biol. 2005, 12, 1221-1226
73. Delfosse, V.; Bouchard, P.; Bonneau, E.; Dagenais, P.; Lemay, J. F.; Lafontaine, D. A.; Legault, P. Riboswitch structure: an internal residue mimicking the purine ligand Nucleic Acids Res. 2010, 38, 2057-2068
74. Pikovskaya, O.; Polonskaia, A.; Patel, D. J.; Serganov, A. Structural principles of nucleoside selectivity in a 2′-deoxyguanosine riboswitch Nat. Chem. Biol. 2011, 7, 748-755
75. Wickiser, J. K.; Winkler, W. C.; Breaker, R. R.; Crothers, D. M. The speed of RNA transcription and metabolite binding kinetics operate an FMN riboswitch Mol. Cell 2005, 18, 49-60
76. Mandal, M.; Boese, B.; Barrick, J. E.; Winkler, W. C.; Breaker, R. R. Riboswitches control fundamental biochemical pathways in Bacillus subtilis and other bacteria Cell 2003, 113, 577-586
77. Mack, M.; van Loon, A. P.; Hohmann, H. P. Regulation of riboflavin biosynthesis in Bacillus subtilis is affected by the activity of the flavokinase/flavin adenine dinucleotide synthetase encoded by ribC J. Bacteriol. 1998, 180, 950-955
78. Lee, E. R.; Blount, K. F.; Breaker, R. R. Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression RNA Biol. 2009, 6, 187-194
79. Ster, C.; Allard, M.; Boulanger, S.; Lamontagne Boulet, M.; Mulhbacher, J.; Lafontaine, D. A.; Marsault, E.; Lacasse, P.; Malouin, F. Experimental treatment of Staphylococcus aureus bovine intramammary infection using a guanine riboswitch ligand analog J. Dairy Sci. 2013, 96, 1000-1008
80. Taylor, E. C.; Loux, H. M.; Falco, E. A.; Hitchings, G. H. Pyrimidopteridines by oxidative self-condensation of aminopyrimidines J. Am. Chem. Soc. 1955, 77, 2243-2248
81. Prochazkova, E.; Jansa, P.; Brezinova, A.; Cechova, L.; Mertlikova-Kaiserova, H.; Holy, A.; Dracinsky, M. Compound instability in dimethyl sulphoxide, case studies with 5-aminopyrimidines and the implications for compound storage and screening Bioorg. Med. Chem. Lett. 2012, 22, 6405-6409
82. De Jonghe, S.; Marchand, A.; Gao, L. J.; Calleja, A.; Cuveliers, E.; Sienaert, I.; Herman, J.; Clydesdale, G.; Sefrioui, H.; Lin, Y. A.; Pfleiderer, W.; Waer, M.; Herdewijn, P. Synthesis and in vitro evaluation of 2-amino-4- N -piperazinyl-6-(3,4-dimethoxyphenyl)-pteridines as dual immunosuppressive and anti-inflammatory agents Bioorg. Med. Chem. Lett. 2011, 21, 145-149
83. Ataide, S. F.; Wilson, S. N.; Dang, S.; Rogers, T. E.; Roy, B.; Banerjee, R.; Henkin, T. M.; Ibba, M. Mechanisms of resistance to an amino acid antibiotic that targets translation ACS Chem. Biol. 2007, 2, 819-827
84. Lunse, C. E.; Schuller, A.; Mayer, G. The promise of riboswitches as potential antibacterial drug targets Int. J. Med. Microbiol. 2014, 304, 79-92
85. Ellington, A. D.; Szostak, J. W. In vitro selection of RNA molecules that bind specific ligands Nature 1990, 346, 818-822
86. Burgstaller, P.; Kochoyan, M.; Famulok, M. Structural probing and damage selection of citrulline- and arginine-specific RNA aptamers identify base positions required for binding Nucleic Acids Res. 1995, 23, 4769-4776
87. Rentmeister, A.; Mayer, G.; Kuhn, N.; Famulok, M. Secondary structures and functional requirements for thiM riboswitches from Desulfovibrio vulgaris, Erwinia carotovora and Rhodobacter spheroides Biol. Chem. 2008, 389, 127-134
88. Mayer, G.; Raddatz, M. S. L.; Grunwald, J. D.; Famulok, M. RNA ligands that distinguish metabolite-induced conformations in the TPP riboswitch Angew. Chem., Int. Ed. 2007, 46, 557-560
89. Rentmeister, A.; Mayer, G.; Kuhn, N.; Famulok, M. Conformational changes in the expression domain of the Escherichia coli thiM riboswitch Nucleic Acids Res. 2007, 35, 3713-3722
90. Mayer, G.; Faulhammer, D.; Grattinger, M.; Fessele, S.; Blind, M. A RNA-based approach towards small-molecule inhibitors ChemBioChem 2009, 10, 1993-1996
91. Zapp, M. L.; Stern, S.; Green, M. R. Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production Cell 1993, 74, 969-978
92. Wang, Y.; Rando, R. R. Specific binding of aminoglycoside antibiotics to RNA Chem. Biol. 1995, 2, 281-290
93. Vicens, Q.; Westhof, E. RNA as a drug target: the case of aminoglycosides ChemBioChem 2003, 4, 1018-1023
94. Schroeder, R.; Waldsich, C.; Wank, H. Modulation of RNA function by aminoglycoside antibiotics EMBO J. 2000, 19, 1-9
95. Posakony, J. J.; Ferre-D'Amare, A. R. Glucosamine and glucosamine-6-phosphate derivatives: catalytic cofactor analogues for the glmS ribozyme J. Org. Chem. 2013, 78, 4730-4743
96. Santner, T.; Rieder, U.; Kreutz, C.; Micura, R. Pseudoknot preorganization of the preQ1 class I riboswitch J. Am. Chem. Soc. 2012, 134, 11928-11931
97. Colizzi, F.; Lamontagne, A. M.; Lafontaine, D. A.; Bussi, G. Probing riboswitch binding sites with molecular docking, focused libraries, and in-line probing assays Methods Mol. Biol. 2014, 1103, 141-151
98. Lunse, C. E.; Scott, F. J.; Suckling, C. J.; Mayer, G. Novel TPP-riboswitch activators bypass metabolic enzyme dependency Front. Chem. (Lausanne, Switz.) 2014, 2, 53
99. Erixon, K. M.; Dabalos, C. L.; Leeper, F. J. Inhibition of pyruvate decarboxylase from Z. mobilis by novel analogues of thiamine pyrophosphate: investigating pyrophosphate mimics Chem. Commun. 2007, 960-962
100. Erixon, K. M.; Dabalos, C. L.; Leeper, F. J. Synthesis and biological evaluation of pyrophosphate mimics of thiamine pyrophosphate based on a triazole scaffold Org. Biomol. Chem. 2008, 6, 3561-3572
101. Fei, X.; Holmes, T.; Diddle, J.; Hintz, L.; Delaney, D.; Stock, A.; Renner, D.; McDevitt, M.; Berkowitz, D. B.; Soukup, J. K. Phosphatase-inert glucosamine 6-phosphate mimics serve as actuators of the glmS riboswitch ACS Chem. Biol. 2014, 9, 2875-2882
102. Ott, E.; Stolz, J.; Lehmann, M.; Mack, M. The RFN riboswitch of Bacillus subtilis is a target for the antibiotic roseoflavin produced by Streptomyces davawensis RNA Biol. 2009, 6, 276-280
103. Pedrolli, D. B.; Matern, A.; Wang, J.; Ester, M.; Siedler, K.; Breaker, R.; Mack, M. A highly specialized flavin mononucleotide riboswitch responds differently to similar ligands and confers roseoflavin resistance to Streptomyces davawensis Nucleic Acids Res. 2012, 40, 8662-8673